The Indian Pharmaceutical Alliance has asked the FDA last month to find a solution for inspecting the manufacturing plants of its members. USFDA classifies Sun Pharma's Halol facility as official ...

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

Sun Pharmaceutical Industries share price gained ... The said subsidiary operates a plant in Saitama, Japan, which manufactures products for Sun Pharma Japan. As part of the sale agreement ...

Puducherry's pharma sector sees 15% annual growth, seeks investments for production expansion, facing competition from Tindivanam Pharma Cluster.

The pharma industry’s overall push into industry 4.0 for manufacturing ... high.” Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer of drugs for pain ...